Newsletter | September 5, 2024

09.05.24 -- What Sites Need: Trial Technology Selection, Buy-In, And Implementation

FEATURED EDITORIAL

What Sites Need: Trial Technology Selection, Buy-In, And Implementation

SCRS Vice President of Site Engagement Jimmy Bechtel poses questions and offers helpful tips aimed at helping sponsors understand site technology needs in this two-part series, with part one focused on technology selection and implementation.

INDUSTRY INSIGHTS

Maximizing Clinical Data Insights With Advanced Analytics Platforms

To achieve drug approval, trials must collect, combine, and analyze diverse data sets that support operational, safety review, risk management, and other analyses crucial to development.

Streamlining Clinical Trials: How To Upgrade From Paper To EDC

Electronic modes have been shown to improve data quality in clinical trials. Address how equivalency can be achieved when migrating PROs from paper to ePRO.

Do We Still Need Patients In Tomorrow's Trials?

Delve into how advanced technologies reshape drug development and patient care, and the crucial balance needed between innovation and ethical responsibility to achieve better trial outcomes.

How Real-World Data Optimized An Oncology Clinical Trial Protocol

Many challenges in running clinical trials are difficult to prepare for, but some, such as trial enrollment and study operational execution, can be proactively addressed thanks to advances in high-quality RWD.

RWD: More Than Just Another Acronym

Uncover how real-world data can not only be used for any type of clinical trial, but study sponsors can also use RWD to inform all stages of a study.

Repositioning Your CDM Team To Meet Digital Trial Demands

Consider these steps when repositioning your clinical data management team to unify cross-functional reviews and align processes and technology to meet the demands of digital trials.